IP Library Granted Patent US 12,514,813
Granted Patent B2
US 12,514,813 · App. 17/996,150 · Granted Jan 6, 2026

Terpene-containing composition and its cosmetic use

Inventors: Stephanie Ferreira Sanches Lopes (São Paulo, BR); Bruna Aline Da Silva Merigiolli (São Paulo, BR); Daniel Nose Sabara (São Paulo, BR); Maria Célia Hibari Reimberg (São Paulo, BR); Naiara Andrade Herculin (São Paulo, BR); Robson José Da Silva Cruz (Levilandia, BR)
Assignee: Beraca Ingredientes Naturais Ltda
A61K8/9789A61K8/31A61K8/361A61Q19/00A61K2800/10A61K2800/75
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,514,813
App. No.
17/996,150
Granted
Jan 6, 2026
Kind
B2
Abstract

The present invention relates to a composition comprising beta-caryophyllene, alpha-humulene, and linoleic acid. Moreover, the present invention refers to a composition comprising a blend of one or more oils from the genus Copaifera and one or more oils from the genus Passiflora . The present invention further relates to a cosmetic product comprising such composition. Furthermore, the present invention relates to a method for preparing such composition and to the use of the composition or the cosmetic product of the present invention for reducing inflammatory responses.

Claims (22)

1 . A composition comprising of:

(A) 45 to 80% by weight of beta-caryophyllene as component A;

(B) 8 to 15% by weight of alpha-humulene as component B;

(C) 5.5 to 8% by weight of a permeation enhancer consisting of linoleic acid as component C; and optionally

(D) 0 to 41.5% by weight of one or more other components which are different from (A), (B) and (C) and which are miscible with (A), (B) and (C) as component D.

2 . The composition of claim 1 , wherein said composition further comprises a blend of:

a) resin oil of the genus Copaifera officinalis as component (E); and

b) seed oil of Passiflora edulis as component (F).

3 . The composition of claim 2 , wherein the weight ratio of components (E):(F) is in the range of 80:20 to 98:2.

4 . A cosmetic product comprising:

(I) 0.1 to 100% by weight of a composition of claim 2 , and optionally

(II) 0 to 99.9% by weight of one or more cosmetically acceptable carriers, fillers, or combinations of carriers and fillers; and optionally

(III) 0 to 50% by weight of one or more further cosmetically acceptable additives, selected from the group consisting of fragrances, dyes, pigments, emulsifiers, lubricants, chelating agents, acidity regulators, antimicrobial agents, preservatives, antioxidants, and combinations of two or more thereof.

5 . The cosmetic product of claim 4 , which is a cosmetic product for external topical use on the skin.

6 . The cosmetic product of claim 4 , wherein said cosmetic product is selected from the group consisting of emulsions, gels, ointments, tonics, liquid soaps, bar soaps, bath oils, shower oils, massage oils, makeups, scalp treatments, aftershaves, shaving products, deodorants, shower gel, shampoos, and combinations of two or more thereof.

7 . A method for preparing a composition of claim 2 comprising the steps of:

(i) providing resin of the genus Copaifera officinalis and seed of Passiflora edulis;

(ii) distilling the resin to obtain resin oil of the genus Copaifera officinalis and distilling the seed to obtain seed oil from the Passiflora edulis wherein the distilling comprises steam distilling conducted at a temperature range of between 100 and 300° C.;

(iii) mixing the resin oil from the genus Copaifera officinalis the seed oil from the Passiflora edulis and optionally one or more further components which are miscible with said oils.

8 . A method for reducing inflammatory responses of the skin by a topical application of the composition of claim 2 , wherein for further increasing the level of beta-endorphin production in the skin.

9 . The composition of claim 2 wherein when applied to the skin, the composition reduces inflammatory responses of the skin, mitigates the effects of premature aging, and supports re-epithelization of the skin.

10 . The composition of claim 9 , wherein the reduced inflammatory responses of the skin improves skin comfort and promotes cutaneous wellbeing.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded May 18, 2026
From: BERACA INGREDIENTES NATURAIS, LTDA; CLARIANT BRASIL LTDA.
To: CLARIANT BRASIL LTDA.
Reel/Frame 074680/0366 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2022
From: LOPES, STEPHANIE FERREIRA SANCHES; MERIGIOLLI, BRUNA ALINE DA SILVA; SABARA, DANIEL NOSE; REIMBERG, MARIA CELIA HIBARI; HERCULIN, NAIARA ANDRADE; DA SILVA CRUZ, ROBSON JOSE
To: BERACA INGREDIENTES NATURAIS LTDA
Reel/Frame 061759/0303 →
Priority Claims (1)
EP 20169551 · Apr 15, 2020 · regional
Continuity (1)
Related Publication 20230210758A1 · Jul 6, 2023
References Cited (3)
US 20160074312A1 · Msika · 2016 [cited by examiner]
WO WO2019136105A1 · 2019 [cited by examiner]
Veiga, V.F., Rosas, E.C., Carvalho, M.V., Henriques, M.G.M.O., Pinto, A.C. “Chemical composition and anti-inflammatory activity of copaiba oils” J. Ethnopharm. 112, pp. 248-254. (Year: 2007). [cited by examiner]